Laurion Capital Management’s Idexx Laboratories IDXX Stock Holding History

Laurion Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-23,263	Closed	-$11.3M	–	443
2024 Q2	$11.3M	Hold	23,263	–	–	0.13%	104
2024 Q1	$12.6M	Buy	+23,263	New	+$12.7M	0.11%	165
2022 Q4	–	Sell	-25,097	Closed	-$8.18M	–	475
2022 Q3	$8.18M	Buy	+25,097	New	+$9.22M	0.05%	203
2022 Q1	–	Sell	-530	Closed	-$349K	–	614
2021 Q4	$349K	Hold	530	–	–	﹤0.01%	447
2021 Q3	$330K	Buy	+530	New	+$356K	﹤0.01%	603
2019 Q4	–	Sell	-1,066	Closed	-$290K	–	1032
2019 Q3	$290K	Sell	1,066 -934	-47%	-$260K	﹤0.01%	873
2019 Q2	$551K	Buy	+2,000	New	+$493K	0.01%	684
2017 Q1	–	Sell	-2,400	Closed	-$281K	–	1419
2016 Q4	$281K	Buy	+2,400	New	+$274K	﹤0.01%	946

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Laurion Capital Management's IDXX Position: Q3 2024 in Review

Laurion Capital Management sold out of Idexx Laboratories (IDXX) in Q3 2024, closing a stake of 23,263 shares — an estimated $11.3M sold.

Laurion Capital Management first reported a position in IDXX in Q4 2016 and held it in 8 quarters. The position peaked at $12.6M in Q1 2024. 1,116 funds tracked by Wall St. Rank hold IDXX as of Q3 2024.

Laurion Capital Management reported no remaining Idexx Laboratories position as of Q3 2024 after selling out during the quarter.
Laurion Capital Management sold 23,263 Idexx Laboratories shares in Q3 2024, an estimated $11.3M.
Laurion Capital Management first reported a position in Idexx Laboratories in Q4 2016 and held it in 8 quarters.
Laurion Capital Management's Idexx Laboratories position peaked at $12.6M in Q1 2024.
1,116 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2024.

Based on Laurion Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.